Navigation Links
Veridiam Names Robert Mazzacavallo New CFO
Date:11/3/2009

SAN DIEGO, Nov. 3 /PRNewswire/ -- Robert Mazzacavallo has joined Veridiam as the company's Chief Financial Officer. San Diego-based Veridiam is a contract manufacturer of high-precision, fabricated assemblies and metal components, primarily serving Fortune 500 companies in the medical devices, power generation, aerospace and general industrial markets.

Before joining Veridiam, Mazzacavallo was Chief Financial Officer at C-Tech Industries in Camas, WA. At C-Tech, Bob worked closely with Andrew Gale, now Veridiam's CEO. Mazzacavallo has spent much of his career assisting mid-sized, multi-site manufacturers grow their business, identify efficiencies, streamline processes and optimize resources.

"Andy Gale has a strong achievable vision for the company and I am looking forward to helping to drive that vision and make it a reality," he continues. "My part in this is to help improve efficiencies, drive out costs and help make Veridiam an even greater success than it is today."

"Among our customers and our competitors, Veridiam is recognized for its unique capabilities and solid reputation for quality," he says. "Veridiam is a gem of a company. I am really excited to be a part of it and to help build upon its successes going forward."

Mazzacavallo sees particular growth potential in nuclear power generation--an industry that Veridiam has been involved in since 1958. "Our capabilities in this area are second to none and our customers are the industry's leaders."

The medical device market also holds tremendous growth potential for Veridiam, Mazzacavallo believes. "Our medical device business has continued to thrive and grow, even in a down economy. We expect this area to expand significantly."

Mazzacavallo holds an MBA in Finance from University of Michigan's Stephen M. Ross School of Business and a BBA in Accounting from University of Notre Dame.

Veridiam, headquartered in El Cajon, CA has two manufacturing facilities in San Diego, CA and a third in San Jose, Costa Rica. Customers include General Electric, Solar Turbines, Hitachi, Toshiba, Boeing, Westinghouse, AREVA, Hologic, Pioneer Surgical and Medtronics. For additional information about Veridiam, visit www.veridiam.com.

SOURCE Veridiam


'/>"/>
SOURCE Veridiam
Copyright©2009 PR Newswire.
All rights reserved

Related medicine technology :

1. Hospira Names Daphne E. Jones Chief Information Officer
2. Premier Research Names Bernard Sweeney as Executive Director, Medical Devices
3. American Hospital Association (AHA) Names OnBase RACTrac Compatible
4. ThermoGenesis Names Jorge Artiles Vice President, Chief Quality and Regulatory Affairs Officer
5. NovaBay Pharmaceuticals Expands Management Team; Names Mark Anderson, Ph.D. as Chief Scientific Officer
6. Boston Business Journal Names NxStage(R) Medical Third Fastest Growing Company in Massachusetts
7. ParagonRx Names Ellen M. Derrico To Chief Marketing Executive Post
8. Zeltiq Aesthetics Names Gordie Nye to Serve as New CEO
9. California Cryobank Names Richard Jennings President of FamilyCord Division
10. Association of Clinical Research Organizations (ACRO) Names Dr. Derek Winstanly Chair-Elect
11. PLC Medical Systems Names Lead Investigators for Pivotal Trial to Evaluate RenalGuard System(TM) and RenalGuard Therapy(TM)
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:12/5/2016)... , Dec. 5, 2016   Lexicon Pharmaceuticals, ... results today from a Phase 2 clinical study of ... Lexicon in collaboration with JDRF, the leading global organization ... of this Phase 2 clinical trial, which randomized a ... of a once-daily 400 mg dose of sotagliflozin compared ...
(Date:12/5/2016)... , December 5, 2016 According to ... Treatment modalities (Chondrocyte Transplantation, Growth Factor Technology, Tissue Scaffolds, Cell-free composites), ... by MarketsandMarkets, the market is projected to reach USD 779.8 Million ... CAGR of 13.5% during the forecast period of 2016 to 2021. ... ...
(Date:12/5/2016)... PORTLAND, Oregon and PUNE, India ... a new report by Allied Market Research, titled, "Global Cancer ... the global revenue of cancer biomarkers market is projected to ... at a CAGR of 13.3% from 2016 to 2022. Omic ... share in 2015 and is expected to maintain its dominance ...
Breaking Medicine Technology:
(Date:12/6/2016)... , ... December 06, 2016 ... ... on Friday, November 25th, when SevenPoint2 released the much-anticipated HydroFX for Water®. ... eye-catching label design. Featuring one of the world’s most powerful antioxidants, molecular ...
(Date:12/6/2016)... ... December 06, 2016 , ... TopConsumerReviews.com recently gave a ... Scooters . , Mobility Scooters give freedom to people who need help getting around. ... may be facing a long period of rehabilitation after an illness or accident. There ...
(Date:12/5/2016)... ... December 05, 2016 , ... "FCPX Overlay Glare is a ... lighting effect without heavy rendering or complicated compositing," said Christina Austin - CEO of ... create an organic spectrum of lights that simulates the look of a glare. ...
(Date:12/5/2016)... GA (PRWEB) , ... December ... ... technology and security executive networking and relationship-marketing firm, announced today that nominations ... the 2017 Information Security Executive® (ISE®) Central Awards. , Awards include the ...
(Date:12/5/2016)... ... December 05, 2016 , ... Physicians Education ... Annual International Congress on Hematologic Malignancies®: Focus on Leukemias, Lymphomas, and Myeloma, on ... “We are honored to have Amy E. Herman present at this year’s conference, ...
Breaking Medicine News(10 mins):